Healthtech deserves more investment

Sign up for the Daily Newsletter, sent exclusively to our premium subscribers. We break down the big and messy topics of Asia’s tech and startup community. Get the newsletter in your inbox everyday with a premium subscription.

Hello reader,

I’ve worked in startups my whole life, and I really like how things in the space move fast. If there’s one thing you can’t accuse the scene of, it’s being boring.

My respect for startups also goes up when we talk about important, impactful fields like cleantech or – the subject of today’s featured article – healthtech. Combine a worthwhile purpose with speedy innovation, and that’s how humanity advances.

But it’s not all smooth sailing, as today’s article explores.

(P.S. Happy National Day to my fellow Singaporeans!)

Today we look at:

• The vital role healthtech startups play in Asia’s future
• The US$8 million series A round of an Indian beauty and cosmetics startup
• Other newsy highlights such as Microsoft and Delta Airlines’ public argument and some chip news from Samsung and Nvidia

Premium summary

Investing in healthtech: A social responsibility

Image credit: Timmy Loen

Healthtech is a big field – from groundbreaking medical advancements to mental health apps and solutions that make hospital bills more transparent, there are myriad ways to help humans live better, happier lives.

Today’s article makes the argument that the field deserves more investment and development. Hard to disagree, I think.

• A sampling of offerings: A number of startups have come up with solutions like AI assessment tools, smart medication dispensers, and mental health apps with self-care programs and online therapy and coaching sessions.
• Not all roses: However, funding is a major challenge. Investors often hesitate to back this sector due to the perceived risks associated with healthcare innovation. Unlike other industries, healthcare startups need substantial investments at the beginning to support research and development, clinical trials, regulatory compliance, and market entry.
• You gotta do it, man: Investors should recognize the unique chance to transform patient outcomes, even while weighing traditional financial metrics such as scalability and market demand. Ultimately, investing in healthcare startups is not only a strategic financial decision but also a social responsibility.

Read more: Why Asia’s future hinges on healthtech startups

If I received US$8 million, I’d certainly say life is kind

Ditch the traffic and hit the fast lane on September 11

Quick bytes